Cargando…

External validity of rct evidence in cost-effectiveness analyses. A review of recent technology appraisals for nice and proposed methods of adjustment

Detalles Bibliográficos
Autores principales:	Mantopoulos, Theodoros, Dias, Sofia, Ades, Antony, Welton, Nicky
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659245/ http://dx.doi.org/10.1186/1745-6215-16-S2-P25

Ejemplares similares

Methods for Population-Adjusted Indirect Comparisons in Health Technology Appraisal
por: Phillippo, David M., et al.
Publicado: (2017)

Equivalence of entropy balancing and the method of moments for matching‐adjusted indirect comparison
por: Phillippo, David M., et al.
Publicado: (2020)

Assessing the performance of population adjustment methods for anchored indirect comparisons: A simulation study
por: Phillippo, David M., et al.
Publicado: (2020)

Evidence Synthesis for Decision Making 3: Heterogeneity—Subgroups, Meta-Regression, Bias, and Bias-Adjustment
por: Dias, Sofia, et al.
Publicado: (2013)

Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
por: Mistry, Hema, et al.
Publicado: (2017)

Target estimands for efficient decision making: Response to comments on “Assessing the performance of population adjustment methods for anchored indirect comparisons: A simulation study”
por: Phillippo, David M., et al.
Publicado: (2021)

Correction to: Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
por: Mistry, Hema, et al.
Publicado: (2019)

Evidence Synthesis for Decision Making 6: Embedding Evidence Synthesis in Probabilistic Cost-effectiveness Analysis
por: Dias, Sofia, et al.
Publicado: (2013)

Multilevel network meta‐regression for population‐adjusted treatment comparisons
por: Phillippo, David M., et al.
Publicado: (2020)

Validating the Assumptions of Population Adjustment: Application of Multilevel Network Meta-regression to a Network of Treatments for Plaque Psoriasis
por: Phillippo, David M., et al.
Publicado: (2022)

Evidence Synthesis for Decision Making 5: The Baseline Natural History Model
por: Dias, Sofia, et al.
Publicado: (2013)

Evidence Synthesis for Decision Making 2: A Generalized Linear Modeling Framework for Pairwise and Network Meta-analysis of Randomized Controlled Trials
por: Dias, Sofia, et al.
Publicado: (2013)

Evidence Synthesis for Decision Making 1: Introduction
por: Dias, Sofia, et al.
Publicado: (2013)

Automated generation of node‐splitting models for assessment of inconsistency in network meta‐analysis
por: van Valkenhoef, Gert, et al.
Publicado: (2015)

The impact of rarity in NICE’s health technology appraisals
por: Clarke, Sophie, et al.
Publicado: (2021)

Extrapolation of Survival Curves from Cancer Trials Using External Information
por: Guyot, Patricia, et al.
Publicado: (2016)

Decision making in NICE single technological appraisals: How does NICE incorporate patient perspectives?
por: Hashem, Ferhana, et al.
Publicado: (2017)

Sensitivity of treatment recommendations to bias in network meta‐analysis
por: Phillippo, David M., et al.
Publicado: (2017)

Issues Related to the Frequency of Exploratory Analyses by Evidence Review Groups in the NICE Single Technology Appraisal Process
por: Kaltenthaler, Eva, et al.
Publicado: (2016)

Accounting for Heterogeneity in Relative Treatment Effects for Use in Cost-Effectiveness Models and Value-of-Information Analyses
por: Welton, Nicky J., et al.
Publicado: (2015)

Biologic agents for rheumatoid arthritis—negotiating the NICE technology appraisals
por: Kiely, Patrick D. W., et al.
Publicado: (2012)

Porting of the CERN-NICE environment to an external site
por: Capiluppi, P, et al.
Publicado: (1997)

NICE technology appraisals: working with multiple levels of uncertainty and the potential for bias
por: Brown, Patrick, et al.
Publicado: (2011)

EMA and NICE Appraisal Processes for Cancer Drugs: Current Status and Uncertainties
por: Dickson, Rumona, et al.
Publicado: (2018)

Evidence Synthesis for Decision Making 7: A Reviewer’s Checklist
por: Ades, A. E., et al.
Publicado: (2013)

Evidence Synthesis for Decision Making 4: Inconsistency in Networks of Evidence Based on Randomized Controlled Trials
por: Dias, Sofia, et al.
Publicado: (2013)

Exploring Treatment by Covariate Interactions Using Subgroup Analysis and Meta-Regression in Cochrane Reviews: A Review of Recent Practice
por: Donegan, Sarah, et al.
Publicado: (2015)

Problem drug use prevalence estimation revisited: heterogeneity in capture–recapture and the role of external evidence
por: Jones, Hayley E., et al.
Publicado: (2016)

Recent NICE guidance of interest to surgeons
por: Campbell, Bruce
Publicado: (2013)

Audit of data redaction practices in NICE technology appraisals from 1999 to 2019
por: Osipenko, Leeza
Publicado: (2021)

Cost-Effectiveness of Sertraline in Primary Care According to Initial Severity and Duration of Depressive Symptoms: Findings from the PANDA RCT
por: Hollingworth, William, et al.
Publicado: (2019)

A threshold analysis assessed the credibility of conclusions from network meta-analysis
por: Caldwell, Deborah M., et al.
Publicado: (2016)

A qualitative study of manufacturers' submissions to the UK NICE single technology appraisal process
por: Kaltenthaler, Eva C, et al.
Publicado: (2012)

It’s not evidence, it’s insight: bringing patients’ perspectives into health technology appraisal at NICE
por: Staley, Kristina, et al.
Publicado: (2016)

Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves
por: Guyot, Patricia, et al.
Publicado: (2012)

Assessing the consistency assumptions underlying network meta‐regression using aggregate data
por: Donegan, Sarah, et al.
Publicado: (2018)

A Review of Issues Affecting the Efficiency of Decision Making in the NICE Single Technology Appraisal Process
por: Walton, M. J., et al.
Publicado: (2019)

The Challenges of Measuring and Valuing Quality of Life in Preschool Children: A Retrospective Review of NICE Appraisals
por: Lamb, Alan, et al.
Publicado: (2021)

Eribulin for Treating Locally Advanced or Metastatic Breast Cancer After One Chemotherapy Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
por: Fleeman, Nigel, et al.
Publicado: (2019)

Recent developments in MAD Version 8 [presented at Nice]
por: Grote, H, et al.
Publicado: (1990)

Cannot write session to /tmp/vufind_sessions/sess_3cn1qo1pa4ki6n2uhmpomc40h1